QA: Epizyme Inc in us_pharma/2015

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001571498_2016_Epizyme_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001571498, Epizyme Inc

  xvar xval
0 AssetsCurrent 213,063,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 4,089,000
3 remainder_Assets 751,000
4 LiabilitiesCurrent 18,449,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 23,900,000
9 ResearchAndDevelopmentExpense 111,209,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 2,733,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 217,903,000
1 Liabilities 18,449,000
2 Expenses 135,109,000
3 Revenues 0
4 StockholdersEquity 199,454,000
5 NetIncome -132,376,000
6 ComprehensiveNetIncome -132,376,000
7 BaseVar 187,097,000
8 EconomicCapitalRatiobeforeLimitedLiability 2.56
9 EconomicCapitalRatio 3.39

Edgar->Model Mapping

Feature Distribution

Change over Time